Kanał SOLV
SO

Solventum

SOLV · NYSE

$88.86 +1.52% (+$1.33)
1M -2.64%
Market Cap $15.4B
P/E Ratio 10.73x
Div. Yield -
ROE 28.96%
Piotroski F-Score Strong
7/9
Valuation
90 /100
Cheap
P/E 10.73x
PEG 0.04x
EV/EBITDA 7.80x
Growth
28 /100
Declining
EPS growth 4.46%
Book val. growth 24.52%
Rev. growth 0.79%
Profitability
69 /100
Strong
Gross margin 54.69%
FCF margin 1.42%
Net margin 17.26%
Quality
84 /100
Excellent
ROIC 15.85%
Asset turnover 0.58x
ROE 28.96%
Debt
57 /100
Moderate
Debt/Equity 1.10x
Net debt/EBITDA 1.88x
Current ratio 1.02x
Stability
67 /100
Stable
Beta 0.69x
Profitable years 4
Rev. volatility 0.09%

Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej

Zapytaj StockBota o SOLV
Online

O spółce

Solventum Corporation is an American technology company that focuses on developing innovative solutions in the fields of chemistry and pharmaceuticals. It specializes in providing services related to research, development, and commercialization of chemical and pharmaceutical products. Solventum Corporation collaborates with pharmaceutical and biotechnology companies to optimize manufacturing processes and develop new active ingredients. The company's goal is to improve the efficiency and safety of chemical processes, with a focus on sustainability and technological innovations.

Opis nie jest jeszcze dostępny w Twoim języku, więc tekst jest po angielsku.

Sector

Healthcare

Industry

Medical - Instruments & Supplies

CEO

Bryan C. Hanson

Employees

20,584

Headquarters

Eagan

Nadchodzące wydarzenia

05 LIS

Earnings

Upcoming earnings report

45d

Używamy niezbędnych plików cookie do działania strony oraz opcjonalnych analitycznych plików cookie do pomiaru ruchu. Zobacz naszą Politykę prywatności.